Related Experiment Video
Updated: Jun 2, 2026

04:16
Intravital Two-Photon Microscopy of the Transplanted Mouse Lung
Published on: April 19, 2024
Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy
Susanna Celli1, Matthew L Albert, Philippe Bousso
1Institut Pasteur, Unité des Dynamiques des Réponses Immunes, Département d'Immunologie, Paris, France.
Nature Medicine
|May 17, 2011
Summary
Host immune cells attack skin grafts, with dendritic cells (DCs) migrating out and being replaced by other host cells. These cells prime T cells, leading to graft rejection, offering targets for immunotherapy.
Area of Science:
- Immunology
- Transplantation Biology
- Cellular and Molecular Medicine
Background:
- Transplant rejection is a complex process involving both innate and adaptive immunity.
- Understanding the roles of donor and host cells is crucial for managing rejection.
- Current models lack the resolution to visualize these dynamic cellular interactions in real-time.
Purpose of the Study:
- To investigate the dynamic cellular mechanisms of transplant rejection using intravital imaging.
- To elucidate the contributions of donor and host cells in the rejection process.
- To define the pathways of antigen presentation and T cell activation in allograft rejection.
Main Methods:
- Development of a novel ear skin graft model compatible with intravital imaging.
- Tracking of donor and host cell migration and interaction within the graft.
- Analysis of T cell priming, trafficking, and targeting of graft cells.
Main Results:
- Donor dermal dendritic cells (DCs) rapidly emigrated from the graft.
- Host CD11b(+) mononuclear cells infiltrated the graft, captured donor antigens, and migrated to lymph nodes.
- Graft-reactive CD8(+) T cells were cross-primed, entered the graft, and selectively targeted graft cells, particularly at the dermis-epidermis junction.
Conclusions:
- The study reveals a stepwise progression of CD8(+) T cell activity during allograft rejection.
- Insights into antigen presentation and T cell targeting provide a framework for evaluating immunotherapies.
- Targeting key steps in T cell-mediated rejection could offer new therapeutic strategies.

